|
|
|
|
With targeted medicines, understanding individual patient characteristics is key to maximizing efficacy and safety. By tailoring treatment regimens, organizations can bridge the gap between preclinical research and clinical development, ensuring regulatory success and improved patient outcomes.
|
|
|
|
|
Drug repurposing, once a niche strategy, is gaining traction thanks to transcriptomics. By analyzing gene expression patterns, researchers can rapidly identify new uses for existing drugs, reducing development time and costs. This approach holds immense potential for addressing unmet medical needs.
|
|
|
|
|
Cutting-edge technologies are revolutionizing how we monitor and ensure patient safety. Join an expert panel discussion as they explore how AI, machine learning, and other innovations are streamlining processes, enhancing accuracy, and empowering safety and clinical teams to make data-driven decisions.
|
|
|
|
|
Fear of CAPAs is a common misconception. While they're regulatory necessities, they're also powerful tools for improving quality and efficiency. Let's explore a structured approach to implementing a robust CAPA framework that benefits both your business and patients.
|
|
|
|
|
Navigating the complex world of TMF audits can be daunting. But with a well-structured audit trail, you can ensure compliance, streamline inspections, and protect your clinical trials. Discover essential strategies for building a robust audit trail that empowers your TMF.
|
|
|
|
|
Although cell and gene therapies (CGTs) are potentially transformative, their effectiveness is undermined by difficulties with patient access and support, high costs, and a complex pathway to treatment. Understand the patient access problems that are inherent with CGTs and the benefits of data collection and integrated patient support hubs.
|
|
|
